PSA welcomes the Pharmacy Guild’s new Executive Director
Suzanne Greenwood, a leader in the not-for-profit hospital and aged care service sectors, has been appointed as the new Executive Director of the Pharmacy...
PSA’s up-to-date COVID-19 advice for pharmacists
As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.
Update on breast cancer risk with HRT
Hormone replacement therapy may pose a risk to the development of breast cancer, according to new research.
The incidence of breast cancer is higher in...
Will a repurposed drug help treat COVID-19?
There are 344 registered interventional clinical trials under way for the treatment and prevention of COVID-19. The WHO is looking at four of them.
NIP access (almost) guaranteed
The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.
COVID-19 rollout strategy recalibrated
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.